federal enforcement actions, filings and court records, from official sources

••• ⚠️ Newsticker presented by CFExclusion.com ⚠️ ••• 🚨 FRAUD WATCH — Federal authorities announced charges against 16 noncitizens in alleged election-related crimes, including illegal voting and fraudulent voter registration; defendants remain presumed innocent.  • 🤖 AI SECURITY — Researchers report autonomous AI agents attempting hacking techniques against government websites, while malicious AI tools are increasingly being used in cyberattacks.  • 💻 ONLINE THEFT — The FBI says multiple suspects have been arrested in the ShinyHunters data-theft investigation following attacks involving stolen information and extortion.  • 🇺🇸 TRUMP — Trump announced a federal “Super Intelligence Force” to coordinate America’s AI strategy and maintain U.S. technological leadership.  • 🏛️ POLITICS — With one month until the midterms, control of Congress is tightening into a major national battle.  • 🔎 AI SCREENING — As fraud, stolen identities and automated attacks accelerate, AI-based scre

Records through Monday, October 12, 2026 DOJ · SEC · FTC · FDA · CFPB · CFTC · FINRA · OCC · Federal Register · CourtListener · SCOTUSblog

U.S. Food and Drug Administration · FDA enforcement report entry

FDA Class II: Amerisource Health Services LLC — Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg

The U.S. Food and Drug Administration listed this entry in its enforcement reports on April 1, 2026. The source link opens the FDA’s recalls, market withdrawals and safety alerts page.

Read the official source on fda.gov →

Issued by: U.S. Food and Drug Administration
Document type: FDA enforcement report entry
Date: April 1, 2026
First recorded by CourtPulse: April 7, 2026 · all records that day
Category: FDA action (assigned by CourtPulse)

CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.

More from U.S. Food and Drug Administration, within 7 days

FDA Class II: SOMERSET THERAPEUTICS LLC — Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Via Mar 25, 2026 · FDA enforcement report entry
FDA Class II: STRIDES PHARMA INC — Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for Mar 25, 2026 · FDA enforcement report entry
FDA Class II: Apotex Corp. — Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Mar 25, 2026 · FDA enforcement report entry
FDA Class II: Chiesi USA, Inc. — CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi US Apr 1, 2026 · FDA enforcement report entry
FDA Class II: Teva Pharmaceuticals USA, Inc — Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL Apr 1, 2026 · FDA enforcement report entry
FDA Class II: Teva Pharmaceuticals USA, Inc — Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL Apr 1, 2026 · FDA enforcement report entry

Get records like this one daily by email →